Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Vieito

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Neuro-Oncology Advances|August 22, 2025
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastomaJames R Whittle, Maria Vieito, Kristoffer Rohrberg, et al.
Nature Communications|April 8, 2026
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trialFrank A Giordano, Julian P Layer, Roberta Turiello, et al.
Molecular Cancer|September 29, 2014
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancerLorena Alonso-Alconada, Laura Muinelo-Romay, Kadri Madissoo, et al.
Molecular Cancer Therapeutics|August 2, 2022
A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of GlioblastomaRaffaella Iurlaro, Inja Waldhauer, Ester Planas-Rigol, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2026
Evolving landscape of targeted therapies in early phase clinical trialsAlice Rossi, Irene Braña, Maria Vieito, et al.
Journal for Immunotherapy of Cancer|February 20, 2025
Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancerAlice Talpin, Ana Maia, Jean-Marie Carpier, et al.
Med (New York, N.Y.)|August 12, 2023
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trialsAlberto Hernando-Calvo, Maria Vila-Casadesús, Yacine Bareche, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Neuro-Oncology Advances|August 22, 2025
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastomaJames R Whittle, Maria Vieito, Kristoffer Rohrberg, et al.
Nature Communications|April 8, 2026
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trialFrank A Giordano, Julian P Layer, Roberta Turiello, et al.
Molecular Cancer|September 29, 2014
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancerLorena Alonso-Alconada, Laura Muinelo-Romay, Kadri Madissoo, et al.
Molecular Cancer Therapeutics|August 2, 2022
A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of GlioblastomaRaffaella Iurlaro, Inja Waldhauer, Ester Planas-Rigol, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2026
Evolving landscape of targeted therapies in early phase clinical trialsAlice Rossi, Irene Braña, Maria Vieito, et al.
Journal for Immunotherapy of Cancer|February 20, 2025
Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancerAlice Talpin, Ana Maia, Jean-Marie Carpier, et al.
Med (New York, N.Y.)|August 12, 2023
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trialsAlberto Hernando-Calvo, Maria Vila-Casadesús, Yacine Bareche, et al.
Pageof 4